ably less invasive surgery for patients without compromising on quality.
While some estimates put the global market for anti-reflection coatings at more than $6.1 billion (€5.17bn) per year by 2021, they have yet to take off because of the high cost of the current technology and the lack of durability in challenging environments.
The advantage of Dr Mokarian’s “Zeroptica” technology is that, as it is solution based, it can be applied to curved surfaces and large areas. Additionally, it doesn’t require expensive equipment or harsh chemicals – both of which can be costly.
While Dr Mokarian and her team have achieved significant funding from both the European Horizon 2020 scheme as well as industry. She recently won an award at the Trinity Innovation Awards.
Dr Mokarian is a senior research fellow at materials centre Amber, which is funded by the Science Foundation Ireland. Including Amber, the project involves 13 partners from six European countries included five multinational companies, four small and medium enterprises, two universities and two research institutes.